Development and validation of a novel method for simultaneous quantification of enzalutamide, darolutamide and their active metabolites in mice dried blood spots using LC-MS/MS: Application to pharmacokinetic study in mice

Authors

  • Neeraj Kumar Saini Jubilant Biosys
  • Suresh P Sulochana Jubilant Biosys
  • Mohd Zainuddin Jubilant Biosys
  • Ramesh Mullangi Jubilant Biosys http://orcid.org/0000-0003-1359-8999

DOI:

https://doi.org/10.5599/admet.557

Keywords:

Enzalutamide, N-desmethylenzalutamide, darolutamide, ORM-15341, dried blood spot, LC-MS/MS, method validation, mice, pharmacokinetics

Abstract

A simple, sensitive and rapid assay method has been developed and validated for the estimation of enzalutamide, N-desmethylenzalutamide (active metabolite of enzalutamide), darolutamide and ORM-15341 (active metabolite of darolutamide) on mice dried blood spots (DBS) using liquid chromatography coupled to tandem mass spectrometry with electro spray ionization in the positive-ion mode. The method utilizes liquid extraction of enzalutamide, N-desmethylenzalutamide, darolutamide and ORM-15341 from 3 mm punched disks from DBS cards (spiked or study samples). The extracted sample was chromatographed using an isocratic mobile phase (0.2 % formic acid : acetonitrile; 30:70, v/v) on an Atlantis dC18 column. The total run time was 2.5 min. The MS/MS ion transitions monitored were m/z 465 → m/z 209, m/z 451 →  m/z 195, m/z 399 → m/z 178, m/z 397 →  m/z 194 and m/z 481 → m/z 453 for enzalutamide, N-desmethyl­enzalutamide, darolutamide, ORM-15341 and the IS (apalutamide-d3), respectively. Method validation was performed as per regulatory guideline. The assay had a good linearity over the range of 0.93-2000 ng/mL. The intra- and inter-batch accuracy and precision (%RE & RSD) across quality controls met the acceptance criteria for all the analytes. Stability studies showed that all the analytes were stable on DBS cards for one month. This novel method has been applied to analyze the DBS samples of enzalutamide, N-desmethylenzalutamide, darolutamide and ORM-15341 obtained from a pharmacokinetic study in mice.

Downloads

Download data is not yet available.

Downloads

Published

22-09-2018

How to Cite

Saini, N. K., Sulochana, S. P., Zainuddin, M., & Mullangi, R. (2018). Development and validation of a novel method for simultaneous quantification of enzalutamide, darolutamide and their active metabolites in mice dried blood spots using LC-MS/MS: Application to pharmacokinetic study in mice. ADMET and DMPK, 6(3), 242–257. https://doi.org/10.5599/admet.557

Issue

Section

Original Scientific Articles

Most read articles by the same author(s)